-
South Africa stun South Korea to make World Cup history
-
Seoul stocks soar in Asia tech rally after Micron blowout forecast
-
Clarke fears Scotland 'probably going home' after Brazil World Cup loss
-
Moriyasu vows Japan will play to win and top group against Sweden
-
Secret cameras, mics and AI reveal rare Cambodia wildlife
-
Beloved spiritual utopia under threat in Modi's India
-
Bulgaria's milk farmers falter in former yogurt empire
-
Ancelotti hails Vinicius as Brazil march on at World Cup
-
Trump opens US 250th birthday party with rally-style speech
-
Morocco have 'ingredients' of World Cup winners, says coach Ouahbi
-
TotalEnergies awaits ruling in high-stakes climate trial
-
'Master key' vaccine technique may 'prevent next pandemic': researchers
-
Spice Girls' debut 'Wannabe' turns 30, amid reunion talk
-
Curacao belong on World Cup stage, says Advocaat
-
Nagelsmann feels Germany 'punished' for topping World Cup group
-
Morocco overcome historic Haiti goals to roll into World Cup last 32
-
Bosnia beat Qatar to reach World Cup knockout stages for first time
-
Twin earthquakes in Venezuela destroy buildings, sow panic
-
Brazil advance at World Cup as Swiss, Canada reach last 32
-
Vinicius Junior sparkles as Brazil beat Scots to reach World Cup last 32
-
Morocco overcome historic Haiti goals to maintain World Cup momentum
-
Two powerful earthquakes strike Venezuela, destroying buildings
-
ICC judges sue Trump over 'draconian' sanctions
-
Australia teen social media ban has little impact: research
-
Space shuttle ready for new mission in California
-
Modigliani nude sets European record at London auction
-
Tunisia coach Renard demands pride in final World Cup outing
-
Trump seeks $88 bn in extra funding, mostly for Iran war
-
Switzerland, Canada advance as Brazil eye last 32
-
Wyatt-Hodge stars as England ease into Women's T20 World Cup semi-finals
-
Bosnia in strong position to reach last 32, Qatar out of World Cup
-
Switzerland down World Cup co-hosts Canada to top Group B, both progress
-
Brent falls below $75 as Nasdaq drops for 3rd straight day
-
'New rules': life in world epicentre of jihadist terror
-
Korda chases 3rd straight major at Women's PGA Championship
-
Trump clashes with Republicans in testy Capitol visit
-
Zimbabwe Senate approves bill to extend presidential term
-
Scheffler says PGA Tour headed 'in right direction' with two-tier system
-
Pulisic fitness boost as US seek knockout momentum against Turkey
-
Mamdani-backed leftist candidates win New York Democratic primaries
-
Hantavirus outbreak should formally end on July 2: WHO
-
Britain's Draper continues promising start under Andy Murray
-
Hong Kong arrests two for allegedly selling 'seditious' material
-
Laporte wary of Uruguay will to avoid World Cup exit against Spain
-
US promises to protect Gulf states' interests in Iran talks
-
Major Nigeria police reform edges forward with senate approval
-
Trials of two Ebola treatments to start in DRC next week: WHO
-
Trump consolidates rightward shift in Latin America
-
Judge asks why Kennedy Center covering facade after Trump's name removed
-
Olympics to offer all Games competitors $10,000 grants
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
CAMBRIDGE, MA / ACCESS Newswire / January 26, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to report its fourth quarter 2025 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
H.Romero--AT